As of Mar 05
| +0.56 / +2.23%|
The 3 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 32.00, with a high estimate of 35.00 and a low estimate of 28.00. The median estimate represents a +24.80% increase from the last price of 25.64.
The current consensus among 4 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.